ReviewBiological reviews of the Cambridge Philosophical Society2026
The power of many: when genetics met yeasts and high-throughput.
Review in Biological reviews of the Cambridge Philosophical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In recent years, complex technological capabilities have evolved, driven by the need to solve complex and integrative biological questions through global analyses. New equipment allows the scaling up and automation of processes which previously were carried out on a very limited scale. Concomitant with the availability of sophisticated technology developed to increase experimental processes in parallel, it is essential to have a versatile biological model that allows us to generate and handle large collections of genetic variants with the greatest possible capacity. This is a critical aspect in order to approach saturation levels in each search, to minimise false-positive and false-negative rates. In this sense, yeasts represent a prototypical eukaryotic model with a remarkable genome editing potential: it is possible to generate and phenotype several thousand genetically diverse strains on a high-throughput scale. Here we review, with a focus on the most recent years, the combination of the power of yeasts with the technical advances in multi-level processing capability. This has resulted in unprecedented global mappings of a multitude of biological processes with important implications that reshape our knowledge of fundamental biology, evolution and biotechnological/biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.